(2007) published in Nature results showing that thymosin beta-4 reactivates epicardial progenitor cells in adult mouse hearts
We explore this topic in more detail here: #GLP1 #RealWorldData #RWE #LifeSciences #Pharma #CommercialStrategy #HealthcareInnovation #NorstellaNorstella To view or add a comment, sign in More Relevant Posts Why Real-World Evidence (#RWE) Creates #Confidence in Healthcare Professionals Randomized clinical trials (RCTs) tell us whether a therapy can work under controlled conditions
Tirzepatide, which activates both GLP-1 and GIP receptors, tends to produce larger triglyceride reductions than semaglutide alone in head-to-head comparisons, likely reflecting the additional metabolic effects of GIP receptor activation on lipid metabolism
Wound Healing 4
identified the first potent inhibitors of human SQOR ( 50 value of 29 nM with suitable physicochemical properties and good cell permeability (Figure 10) ( 50 values for the respiratory complexes I, II, and III, dihydroorotate dehydrogenase, and electron transferring flavoprotein:ubiquinone oxidoreductase were all at least 1,000-fold higher than the IC 50 for SQOR ( 50 , of 56 M) and in neonatal rat ventricular cardiomyocytes (CC 50 of 26 M)